Yifan Biologics (688382.SH) surged 7.89% to close at ¥38.95 on July 15, while simultaneously registering five block trades totaling 1.452 million shares worth ¥49.2083 million. Notably, all transactions occurred at a uniform price of ¥33.89 per share, representing a significant 12.99% discount to the day's closing price.
Institutional investors dominated the buying activity, accounting for four transactions worth ¥46.77 million combined. These institutional purchases were executed through specialized institutional trading seats, with China International Capital Corporation (CICC) Shanghai Branch serving as the exclusive seller. The trades comprised: - A ¥25.4175 million transaction for 750,000 shares - A ¥10.167 million transaction for 300,000 shares - A ¥8.4725 million transaction for 250,000 shares - A ¥2.7112 million transaction for 80,000 shares
The remaining transaction, valued at ¥2.4401 million for 72,000 shares, was facilitated by J.P. Morgan Securities (China) Company Limited Shanghai Yincheng Road Branch as the buyer.
This activity continues a trend of substantial block trading for Yifan Biologics, with 34 such transactions totaling ¥183 million occurring over the past three months. Despite recent gains—the stock has risen 24.72% over the last five trading sessions—main funds recorded a net outflow of ¥4.6787 million during this period.
Comments